Century Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $9.6M | $-106.4M | $27.2M |
| FY2021 | $8.9M | $396.2M | $56.4M |
| FY2022 | $3.7M | $302.7M | $84.3M |
| FY2023 | — | $184.8M | $47.3M |
| FY2024 | — | $161.4M | $58.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $9.6M | $-106.4M | $27.2M |
| FY2021 | $8.9M | $396.2M | $56.4M |
| FY2022 | $3.7M | $302.7M | $84.3M |
| FY2023 | — | $184.8M | $47.3M |
| FY2024 | — | $161.4M | $58.4M |